| 2025-11-12 |
详情>>
内部人交易：
O'Brien Dana C.股份减少1000.00股
|
| 2025-11-04 |
详情>>
股本变动：
变动后总股本3071.94万股
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益6.64美元,归母净利润2.03亿美元,同比去年增长40.42%
|
| 2025-11-03 |
财报披露：
美东时间 2025-11-03 盘后发布财报
|
| 2025-08-05 |
详情>>
业绩披露：
2025年中报每股收益3.62美元,归母净利润1.10亿美元,同比去年增长33.21%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益1.29美元,归母净利润3947.70万美元,同比去年增长27.15%
|
| 2025-03-25 |
股东大会：
将于2025-05-08召开股东大会
会议内容 ▼▲
- 1.To elect the six director nominees, named in the accompanying proxy statement, to our board of directors;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2025;
4.To transact such other business as may properly come before the annual meeting.
|
| 2025-02-26 |
详情>>
业绩披露：
2024年年报每股收益8.35美元,归母净利润2.57亿美元,同比去年增长85.68%
|
| 2025-02-26 |
详情>>
业绩披露：
2022年年报每股收益3.53美元,归母净利润9671.70万美元,同比去年增长54.39%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益4.67美元,归母净利润1.44亿美元,同比去年增长46.47%
|
| 2024-08-06 |
详情>>
业绩披露：
2023年中报每股收益1.93美元,归母净利润5912.90万美元,同比去年增长30.78%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益2.68美元,归母净利润8292.70万美元,同比去年增长40.25%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益1.00美元,归母净利润3104.80万美元,同比去年增长58.01%
|
| 2024-03-26 |
股东大会：
将于2024-05-09召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees, named in the accompanying proxy statement, to our board of directors;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2024;
4.To adopt the second amended and restated 2018 stock incentive plan;
5.To transact such other business as may properly come before the annual meeting.
|
| 2024-02-27 |
详情>>
业绩披露：
2023年年报每股收益4.51美元,归母净利润1.39亿美元,同比去年增长43.36%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益3.20美元,归母净利润9848.20万美元,同比去年增长31.77%
|
| 2023-03-24 |
股东大会：
将于2023-05-03召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statement;
2.To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of common stock to 58,000,000 shares;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To approve, on an advisory basis, the frequency of future advisory votes on the compensation of our named executive officers;
5.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2023;
6.To transact such other business as may properly come before the annual meeting.
|
| 2022-03-23 |
股东大会：
将于2022-05-04召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statement;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2022;
4.To transact such other business as may properly come before the annual meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-24 |
股东大会：
将于2021-05-05召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statement;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2021;
4.To adopt the amended and restated 2018 stock incentive plan;
5.To transact such other business as may properly come before the annual meeting.
|
| 2020-03-25 |
股东大会：
将于2020-05-06召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statem
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2020;
4.To transact such other business as may properly come before the annual meeting.
|
| 2019-03-26 |
股东大会：
将于2019-05-08召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees named in the accompanying proxy statement;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2019;
4.To adopt the 2019 Employee Stock Purchase Plan;
5.To transact such other business as may properly come before the annual meeting.
|
| 2018-03-20 |
股东大会：
将于2018-05-02召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees named in the accompanying proxy statement;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2018;
4.To adopt the 2018 stock incentive plan;
5.To transact such other business as may properly come before the annual meeting.
|
| 2017-03-17 |
股东大会：
将于2017-04-28召开股东大会
会议内容 ▼▲
- 1. To elect seven Board nominees, each to serve for a term of one year and until their successors are duly elected and qualified.
2. To approve the adoption by the Board of Directors of an amendment of Article IV of the Company's Certificate of Incorporation to increase the number of shares of common stock that the Company is authorized to issue from 28 million shares to 38 million shares.
3. To approve the adoption by the Board of Directors of an amendment of Article VI of the Company's Certificate of Incorporation to provide for the removal of directors without cause.
4. To ratify the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for 2017.
5. An advisory vote to approve named executive officer compensation.
6. An advisory vote to select the frequency of executive compensation votes.
7. To transact any other business that properly comes before the meeting.
|
| 2016-03-24 |
股东大会：
将于2016-05-06召开股东大会
会议内容 ▼▲
- 1. To elect five Board nominees, each to serve for a term of one year and until their successors are duly elected and qualified.
2. To ratify the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for 2016.
3. An advisory vote to approve named executive officer compensation.
4. To transact any other business that properly comes before the meeting.
|